JOM KITA KE POLITEKNIK

Robust Early Pregnancy Prediction of Later Preeclampsia Using Metabolomic Biomarkers (Record no. 943)

MARC details
042 ## - AUTHENTICATION CODE
Authentication code dc
100 10 - MAIN ENTRY--PERSONAL NAME
Personal name Kenny, Louise C.
Relator term author
9 (RLIN) 2659
245 00 - TITLE STATEMENT
Title Robust Early Pregnancy Prediction of Later Preeclampsia Using Metabolomic Biomarkers
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Date of publication, distribution, etc. 2010-10-01.
500 ## - GENERAL NOTE
General note /pmc/articles/PMC7614124/
500 ## - GENERAL NOTE
General note /pubmed/20837882
520 ## - SUMMARY, ETC.
Summary, etc. Preeclampsia is a pregnancy-specific syndrome that causes substantial maternal and fetal morbidity and mortality. The etiology is incompletely understood, and there is no clinically useful screening test. Current metabolomic technologies have allowed the establishment of metabolic signatures of preeclampsia in early pregnancy. Here, a 2-phase discovery/validation metabolic profiling study was performed. In the discovery phase, a nested case-control study was designed, using samples obtained at 15±1 weeks' gestation from 60 women who subsequently developed preeclampsia and 60 controls taking part in the prospective Screening for Pregnancy Endpoints cohort study. Controls were proportionally population matched for age, ethnicity, and body mass index at booking. Plasma samples were analyzed using ultra performance liquid chromatography-mass spectrometry. A multivariate predictive model combining 14 metabolites gave an odds ratio for developing preeclampsia of 36 (95% CI: 12 to 108), with an area under the receiver operator characteristic curve of 0.94. These findings were then validated using an independent case-control study on plasma obtained at 15±1 weeks from 39 women who subsequently developed preeclampsia and 40 similarly matched controls from a participating center in a different country. The same 14 metabolites produced an odds ratio of 23 (95% CI: 7 to 73) with an area under receiver operator characteristic curve of 0.92. The finding of a consistent discriminatory metabolite signature in early pregnancy plasma preceding the onset of preeclampsia offers insight into disease pathogenesis and offers the tantalizing promise of a robust presymptomatic screening test. (Hypertension. 2010;56:741-749.)
540 ## - TERMS GOVERNING USE AND REPRODUCTION NOTE
Terms governing use and reproduction
546 ## - LANGUAGE NOTE
Language note en
690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN)
Topical term or geographic name as entry element Article
655 7# - INDEX TERM--GENRE/FORM
Genre/form data or focus term Text
Source of term local
700 10 - ADDED ENTRY--PERSONAL NAME
Personal name Broadhurst, David I.
Relator term author
9 (RLIN) 2660
700 10 - ADDED ENTRY--PERSONAL NAME
Personal name Dunn, Warwick
Relator term author
9 (RLIN) 2661
700 10 - ADDED ENTRY--PERSONAL NAME
Personal name Brown, Marie
Relator term author
9 (RLIN) 2662
700 10 - ADDED ENTRY--PERSONAL NAME
Personal name North, Robyn A.
Relator term author
9 (RLIN) 2663
700 10 - ADDED ENTRY--PERSONAL NAME
Personal name McCowan, Lesley
Relator term author
9 (RLIN) 2664
700 10 - ADDED ENTRY--PERSONAL NAME
Personal name Roberts, Claire
Relator term author
9 (RLIN) 2665
700 10 - ADDED ENTRY--PERSONAL NAME
Personal name Cooper, Garth J.S.
Relator term author
9 (RLIN) 2666
700 10 - ADDED ENTRY--PERSONAL NAME
Personal name Kell, Douglas B.
Relator term author
9 (RLIN) 2667
700 10 - ADDED ENTRY--PERSONAL NAME
Personal name Baker, Philip N.
Relator term author
9 (RLIN) 2668
786 0# - DATA SOURCE ENTRY
Note Hypertension
856 41 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="http://dx.doi.org/10.1161/HYPERTENSIONAHA.110.157297">http://dx.doi.org/10.1161/HYPERTENSIONAHA.110.157297</a>
Public note Connect to this object online.

No items available.